Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer

BACKGROUND: A previous phase I/II C-TASK FORCE study of trifluridine/tipiracil plus bevacizumab for patients with heavily pretreated metastatic colorectal cancer (mCRC) showed promising activity with an acceptable toxicity profile. This retrospective study aimed to investigate the safety and efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotani, Daisuke, Kuboki, Yasutoshi, Horasawa, Satoshi, Kaneko, Asumi, Nakamura, Yoshiaki, Kawazoe, Akihito, Bando, Hideaki, Taniguchi, Hiroya, Shitara, Kohei, Kojima, Takashi, Tsuji, Akihito, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935149/
https://www.ncbi.nlm.nih.gov/pubmed/31881856
http://dx.doi.org/10.1186/s12885-019-6475-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935149/
https://www.ncbi.nlm.nih.gov/pubmed/31881856
http://dx.doi.org/10.1186/s12885-019-6475-6

Ejemplares similares